For example, FISH detection of BCR/ABL1 translocation, HER2 amplification, and ALK rearrangement is critical for guiding targeted therapy in chronic myeloid leukemia [5], breast cancer [6,7] and lung adenocarcinoma, respectively [8,9]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.